News

Genprex Granted FDA Orphan Drug Designation (ODD) for REQORSA® Immunogene Therapy for the Treatment of Small Cell Lung Cancer

ODD is in addition to Three FDA Fast Track Designations Genprex expects to dose the first patient in the Acclaim-3 clinical trial in the fourth quarter of 2023 AUSTIN, Texas, Aug. 10, 2023 /PRNewswire/ — […]

News

EMS Encounters for Firearm-Related Injuries Concentrated in Areas of Greatest Socioeconomic Vulnerability

AUSTIN, Texas–(BUSINESS WIRE)–ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies, has released findings focusing on EMS encounters for patients with firearm injuries. The analysis […]